India Emerging Infectious Disease Diagnostics Market to Grow with a CAGR of 9.87% through 2030
Growth in research and development activities is expected to drive the India
Emerging Infectious Disease Diagnostics Market growth in the forecast period,
2026-2030
According to TechSci Research report, “India
Emerging Infectious Disease Diagnostics Market, By Region, Competition,
Forecast and Opportunities, 2020-2030”, the India Emerging Infectious Disease Diagnostics
Market stood at USD 317.63 million in 2024 and is anticipated to grow with a
CAGR of 9.87% through2030. Government initiatives aimed at advancing emerging infectious disease diagnostics have created favorable market conditions for the India Emerging Infectious Disease Diagnostics Market. Several factors contribute to the growth of various emerging infectious disease diagnostics products.
The government is actively fostering collaborations across different sectors, including clinicians, academia, and industry, to effectively combat infectious diseases. For example, partnerships with organizations like the CDC aim to enhance India's emergency response capabilities crucial for tackling infectious diseases. These collaborations involve joint training programs, information sharing, and resource allocation to address current and future health challenges comprehensively.
Also, the government has implemented comprehensive policies geared towards bolstering the country's public health surveillance capabilities by 2035. These policies seek to establish a robust and integrated surveillance system capable of detecting and responding to outbreaks promptly. As part of these endeavors, the Ayushman Bharat scheme has been rolled out, aiming not only to provide access to healthcare services but also to establish health and wellness centers nationwide. These centers play a pivotal role in promoting preventive care and early disease detection, thereby contributing significantly to improved public health outcomes.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "India Emerging Infectious Disease Diagnostics Market”
The escalating incidence of emerging infectious diseases in India stands as a pivotal trend propelling market growth. Key factors such as globalization, urbanization, population density, climate change, and zoonotic transmission mechanisms collectively contribute to the emergence and dissemination of infectious diseases. This trend underscores the pressing need for accurate and rapid diagnostics to promptly identify and manage these diseases effectively.
In India, the recognition of the critical importance of early detection and swift response to infectious diseases is on the rise. Timely diagnosis not only facilitates effective disease management but also plays a pivotal role in curbing disease transmission and implementing appropriate treatment modalities. As such, the future trajectory of the market hinges significantly on the demand for advanced diagnostic tools capable of delivering swift and precise results.
Healthcare professionals increasingly prioritize interventions initiated promptly upon diagnosis, underscoring the necessity for diagnostic solutions that offer expedited and accurate outcomes. This imperative underscores the pivotal role of advanced diagnostic technologies in enabling healthcare providers to promptly initiate targeted interventions, thereby mitigating disease burden and enhancing public health outcomes.
Recognizing the paramount importance of research and development (R&D), the Indian government has fervently supported numerous research initiatives spanning various domains. Notably, the Department of Biotechnology (DBT) has emerged as a key proponent, actively funding and promoting an extensive array of projects aimed at fostering groundbreaking and innovative diagnostic tools for infectious diseases. These endeavors not only contribute to the advancement of healthcare but also play a pivotal role in addressing the dynamic challenges posed by infectious diseases.
Also, the Indian Council of Medical Research (ICMR) has spearheaded several comprehensive programs and initiatives designed to nurture and facilitate cutting-edge research within the realm of infectious diseases. Through these initiatives, ICMR endeavors to cultivate collaboration, foster innovation, and foster knowledge-sharing among researchers, scientists, and healthcare practitioners. By steadfastly investing in research endeavors and fostering an environment conducive to scientific exploration, the Indian government is laying the groundwork for significant breakthroughs in understanding, preventing, and treating infectious diseases.
The India Emerging Infectious Disease Diagnostics
Market is segmented into infection type, technology, regional distribution, and
company.
Based on its technilogy, The polymerase chain reaction (PCR) segment is poised for rapid growth in the forecast period, driven by its exceptional accuracy and sensitivity in detecting infectious diseases. PCR tests have emerged as indispensable tools due to their ability to amplify even minute samples of DNA or RNA, facilitating the identification of infectious agents, particularly in the early stages of infection. This capability renders PCR tests invaluable for disease management and control efforts.
Based on region, West India segment is expected to
grow during the forecast period. The increased prevalence of insurance coverage within the region serves as a pivotal factor driving the heightened utilization of diagnostic services. This expanded insurance penetration not only furnishes individuals with financial security but also serves as a substantial catalyst for the amplified uptake of essential healthcare services. Consequently, this phenomenon stimulates overall market growth by incentivizing a larger demographic to actively seek and avail themselves of these indispensable healthcare offerings.
Major
companies operating in India Emerging Infectious Disease Diagnostics Market
are:
- Abbott
India Ltd.
- Becton
Dickinson and Company
- bioMérieux
India Private Limited
- Bio-Rad
laboratories Inc
- Danaher
Corporation
- Roche Products (India) Pvt. Ltd.
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“Growing application of emerging infectious disease
diagnostics in various end user industries are key drivers of the emerging
infectious disease diagnostics market. Growth in competitive landscape and
presence of well-established companies in the market who are dedicated to
enhance their productivity of emerging infectious disease diagnostics with
every passing year are anticipated to register an impressive grow to India
Emerging Infectious Disease Diagnostics Market in the forecast period”, said
Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“India Emerging Infectious Disease Diagnostics Market By Infection Type (Bacterial, Viral, Fungal, Others), By Technology (Polymerase Chain Reaction (PCR), Immunodiagnostics, Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), Others), By Region, Competition, Forecast and Opportunities, 2020-2030F”, has evaluated
the future growth potential of India Emerging Infectious Disease Diagnostics
Market and provides statistics & information on market size, structure, and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in India Emerging Infectious
Disease Diagnostics Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com